CLOUDR GROUP LTD. (H3L) - Net Assets
Based on the latest financial reports, CLOUDR GROUP LTD. (H3L) has net assets worth €820.52 Million EUR (≈ $959.28 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.15 Billion ≈ $2.52 Billion USD) and total liabilities (€1.33 Billion ≈ $1.56 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are CLOUDR GROUP LTD.'s assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €820.52 Million |
| % of Total Assets | 38.08% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 6.34 |
CLOUDR GROUP LTD. - Net Assets Trend (2021–2024)
This chart illustrates how CLOUDR GROUP LTD.'s net assets have evolved over time, based on quarterly financial data. Also explore how large is CLOUDR GROUP LTD.'s balance sheet for the complete picture of this company's asset base.
Annual Net Assets for CLOUDR GROUP LTD. (2021–2024)
The table below shows the annual net assets of CLOUDR GROUP LTD. from 2021 to 2024. For live valuation and market cap data, see CLOUDR GROUP LTD. market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €1.43 Billion ≈ $1.67 Billion |
-18.84% |
| 2023-12-31 | €1.77 Billion ≈ $2.06 Billion |
-6.17% |
| 2022-12-31 | €1.88 Billion ≈ $2.20 Billion |
+126.29% |
| 2021-12-31 | €-7.16 Billion ≈ $-8.37 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to CLOUDR GROUP LTD.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 252841100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €11.89 Billion | 817.55% |
| Total Equity | €1.45 Billion | 100.00% |
CLOUDR GROUP LTD. Competitors by Market Cap
The table below lists competitors of CLOUDR GROUP LTD. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Quality & Reliability A.B.E.E
AT:QUAL
|
$42.31 Million |
|
Information and Communication Networks Public Company Limited
BK:ICN
|
$42.32 Million |
|
Corentec Co Ltd
KQ:104540
|
$42.33 Million |
|
PCF Group SA
WAR:PCF
|
$42.33 Million |
|
Azion Corporation
TWO:6148
|
$42.29 Million |
|
Panstar Enterprise Co.Ltd
KQ:054300
|
$42.27 Million |
|
Biokarpet S.A.
AT:BIOKA
|
$42.22 Million |
|
Juic International
TWO:6114
|
$42.20 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CLOUDR GROUP LTD.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,825,330,000 to 1,453,747,000, a change of -371,583,000 (-20.4%).
- Net loss of 516,409,000 reduced equity.
- Share repurchases of 7,962,000 reduced equity.
- Other factors increased equity by 152,788,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-516.41 Million | -35.52% |
| Share Repurchases | €7.96 Million | -0.55% |
| Other Changes | €152.79 Million | +10.51% |
| Total Change | €- | -20.36% |
Book Value vs Market Value Analysis
This analysis compares CLOUDR GROUP LTD.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €-12.16 | €0.06 | x |
| 2022-12-31 | €3.15 | €0.06 | x |
| 2023-12-31 | €3.11 | €0.06 | x |
| 2024-12-31 | €2.48 | €0.06 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CLOUDR GROUP LTD. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -35.52%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -14.80%
- • Asset Turnover: 1.23x
- • Equity Multiplier: 1.96x
- Recent ROE (-35.52%) is above the historical average (-36.14%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | -235.60% | 0.70x | 0.00x | €-3.43 Billion |
| 2022 | -91.33% | -56.52% | 1.05x | 1.53x | €-1.87 Billion |
| 2023 | -17.70% | -8.75% | 1.25x | 1.61x | €-505.60 Million |
| 2024 | -35.52% | -14.80% | 1.23x | 1.96x | €-661.78 Million |
Industry Comparison
This section compares CLOUDR GROUP LTD.'s net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $877,583,665
- Average return on equity (ROE) among peers: -5.35%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CLOUDR GROUP LTD. (H3L) | €820.52 Million | 0.00% | 1.63x | $42.29 Million |
| AKSO HEALTH GR. (SPADR)/3 (8HX) | $138.42 Million | -6.83% | 0.03x | $1.60 Billion |
| EDAP TMS S.A (EDA) | $27.36 Million | 5.53% | 0.94x | $128.94 Million |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) | $7.02 Billion | 13.96% | 0.74x | $434.48 Million |
| Medios AG (ILM1) | $341.07K | 0.00% | 1.52x | $367.06 Million |
| M1 Kliniken AG (M12) | $15.12 Million | 0.72% | 0.48x | $300.08 Million |
| Paragon Care Limited (PXS) | $192.32 Million | -7.48% | 1.00x | $130.61 Million |
| Sigma Healthcare Limited (S5YA) | $476.74 Million | -2.59% | 1.54x | $19.74 Billion |
| TELES Informationstechnologien AG (TLIK) | $-10.33 Million | 0.00% | 0.00x | $2.20 Million |
| COSMOS HEALTH NEW DL-01 (V67A) | $36.04 Million | -51.45% | 0.83x | $13.42 Million |
About CLOUDR GROUP LTD.
ClouDr Group Limited provides supplies and software as a service (SaaS) installation to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. The company's integrated in-hospital solution offers an AI-driven extensive hospital SaaS to assist doctors in diagnosis and treatment, and… Read more